Anand C. Patel

Anand is Senior Partner and Senior Vice President, Product Concept Innovation. In this role, he leads a team working on explorations with our Innovation Supply Chain partners to surface new product concepts and identify the most promising opportunities to take forward within the Flagship ecosystem. He also supports product concept innovation for Pioneering Medicines’ portfolio of therapeutics programs.

Anand is an industry executive with significant large-pharma drug development experience, informed by years of work in scientific research and clinical care.

Prior to joining Flagship in 2021, Anand was at EMD Serono for five years, where he most recently served as Senior Medical Director, Neurology & Immunology. Among other responsibilities, he led clinical development and supported global regulatory activities for evobrutinib, an investigational, oral, highly selective Bruton's Tyrosine Kinase inhibitor across a variety of indications in autoimmunity and neurology through phase 2b and the start of phase 3 trials. Anand was the Business Process Owner for the Clinical Study Protocol Development process serving as the first BPO in the company’s Business Process Management 2.0 initiative, and in that capacity was also involved in revisions to other internal governance processes. Prior to EMD Serono, he was at Pfizer, where he was a Precision Medicine and Clinical Lead and advanced the clinical development and regulatory strategy for the firm’s Cystic Fibrosis programs, as well as assets in the pulmonary, autoimmune, and medical dermatology therapeutic areas.

Prior to joining Pfizer in 2014, Anand spent 9 years in academic medicine departing as Assistant Professor of Pediatrics and Medicine at the Washington University School of Medicine, after completing his training in Pediatric Pulmonology at the institution. While at the University, he provided care to patients and undertook research projects spanning basic research in airway biology and immunology, and extended that work into translational studies of asthma, COPD, primary ciliary dyskinesia. In addition, he also worked in the clinical research space on projects in asthma, cystic fibrosis, lung transplantation, and sleep medicine. This broad body of work led to several peer-reviewed publications in leading journals.

Anand trained in Pediatrics at SUNY Stony Brook, received his MD from Rush Medical College in Chicago, his MS in Bioinformatics from the Johns Hopkins University, and his BS from the University of Illinois at Urbana-Champaign.